GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » Return-on-Tangible-Equity

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Return-on-Tangible-Equity : 14.65% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Beijing Chunlizhengda Medical Instruments Co's annualized net income for the quarter that ended in Dec. 2023 was HK$425.2 Mil. Beijing Chunlizhengda Medical Instruments Co's average shareholder tangible equity for the quarter that ended in Dec. 2023 was HK$2,902.1 Mil. Therefore, Beijing Chunlizhengda Medical Instruments Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was 14.65%.

The historical rank and industry rank for Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity or its related term are showing as below:

HKSE:01858' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.82   Med: 16.77   Max: 36.12
Current: 7.82

During the past 11 years, Beijing Chunlizhengda Medical Instruments Co's highest Return-on-Tangible-Equity was 36.12%. The lowest was 7.82%. And the median was 16.77%.

HKSE:01858's Return-on-Tangible-Equity is ranked better than
62.5% of 760 companies
in the Medical Devices & Instruments industry
Industry Median: 1.32 vs HKSE:01858: 7.82

Beijing Chunlizhengda Medical Instruments Co Return-on-Tangible-Equity Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co Return-on-Tangible-Equity Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.12 34.59 19.63 11.96 10.36

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.19 - 8.32 14.65 8.04

Competitive Comparison of Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity

For the Medical Devices subindustry, Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity falls into.



Beijing Chunlizhengda Medical Instruments Co Return-on-Tangible-Equity Calculation

Beijing Chunlizhengda Medical Instruments Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=303.878/( (2882.835+2983.651 )/ 2 )
=303.878/2933.243
=10.36 %

Beijing Chunlizhengda Medical Instruments Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=425.24/( (2820.484+2983.651)/ 2 )
=425.24/2902.0675
=14.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Beijing Chunlizhengda Medical Instruments Co  (HKSE:01858) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Beijing Chunlizhengda Medical Instruments Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Traded in Other Exchanges
Address
No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN
Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Citigroup Inc. 2502 Approved lending agent
Fidelity China Special Situations Plc 2101 Beneficial owner
Taiping Assets Management (hk) Company Limited 2102 Investment manager
Taiping Trustees Limited 2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines